IP Verse

Boehringer Ingelheim Pharmaceuticals competitive analysis

Latest publications and patents of Boehringer Ingelheim Pharmaceuticals New

Explore the latest publications and patents granted to Boehringer Ingelheim Pharmaceuticals, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Boehringer Ingelheim Pharmaceuticals

Discover the latest PTAB cases involving Boehringer Ingelheim Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 3, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Boehringer Ingelheim Pharmaceuticals

IPR2017-02032Aug 31, 2017BOEHRINGER INGELHEIM PHARMACEUTICALSGENENTECHTerminated
IPR2017-02031Aug 31, 2017BOEHRINGER INGELHEIM PHARMACEUTICALSGENENTECHTerminated
IPR2017-02029Aug 31, 2017BOEHRINGER INGELHEIM PHARMACEUTICALSGENENTECHTerminated-Settled
IPR2016-01566Aug 10, 2016MYLAN PHARMACEUTICALSBOEHRINGER INGELHEIM PHARMACEUTICALSInstitution Denied
IPR2016-01565Aug 10, 2016MYLAN PHARMACEUTICALSBOEHRINGER INGELHEIM PHARMACEUTICALSTerminated
IPR2016-01564Aug 10, 2016MYLAN PHARMACEUTICALSBOEHRINGER INGELHEIM PHARMACEUTICALSTerminated
IPR2016-01563Aug 10, 2016MYLAN PHARMACEUTICALSBOEHRINGER INGELHEIM PHARMACEUTICALSTerminated
IPR2015-00418Dec 15, 2014BOEHRINGER INGELHEIM PHARMACEUTICALSBIOGENInstitution Denied
IPR2015-00417Dec 15, 2014BOEHRINGER INGELHEIM PHARMACEUTICALSGENENTECHTerminated-Settled
IPR2015-00415Dec 15, 2014BOEHRINGER INGELHEIM PHARMACEUTICALSGENENTECHTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Boehringer Ingelheim Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
BOEHRINGER INGELHEIM PHARMACEUTICALS - - 64Aggressive
BIOGEN4 - - 12Balanced
GENENTECH - 86 - 65Non-Active
MYLAN PHARMACEUTICALS - - 94 - Highly Aggressive